Jeff Busch

Insider profile

Currently holds positions in Avant Diagnostics Inc, OncBioMune Pharmaceuticals Inc and Chiron Real Estate Inc

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 29% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board Avant Diagnostics Inc May 25, 2018 -
Chairman of the Board OncBioMune Pharmaceuticals Inc June 5, 2020 -
Chairman of the Board, President, Chief Executive Officer Chiron Real Estate Inc Aug. 20, 2017 -
Director Chiron Real Estate Inc None -
Jeff Busch's trades of Chiron Real Estate Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
201.39
Quantity 24,538 +10.0%
Value US$3,116,843
Transaction date
Purchase
Price
369.26
Quantity 31,913 +40.0%
Value US$1,989,526
Transaction date
Purchase
Price
268.92
Quantity 89,444 -16.1%
Value US$3,421,880
Transaction date
Purchase
Price
13.39
Quantity 10,000 +34.8%
Value US$133,900
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-03-04 2022-03-03
B Purchase
24,538 +10.0%
201.39
US$3,116,843 		24,538 +10.0% 201.39 US$3,116,843
2021-03-09 2021-03-08
B Purchase
31,913 +40.0%
369.26
US$1,989,526 		31,913 +40.0% 369.26 US$1,989,526
2021-03-09 2021-03-08
B Purchase
89,444 -16.1%
268.92
US$3,421,880 		89,444 -16.1% 268.92 US$3,421,880
2020-08-10 2020-08-07
B Purchase
10,000 +34.8%
13.39
US$133,900 		10,000 +34.8% 13.39 US$133,900